Download
1 / 9
120 likes | 483 Vues
Hematology/Oncology Fellowship. Kristie A. Blum, M.D. Gregory Otterson, M.D. The Ohio State University Department of Medicine, Division of Hematology & Oncology and The Comprehensive Cancer Center. ABIM Fellowship Requirements. Hematology Board eligible – 2 year program
E N D
Hematology/Oncology Fellowship Kristie A. Blum, M.D. Gregory Otterson, M.D. The Ohio State University Department of Medicine, Division of Hematology & Oncology and The Comprehensive Cancer Center
ABIM Fellowship Requirements • Hematology Board eligible – 2 year program • 12 months clinical service time • 12 months research • Laboratory or Clinical • ½ day continuity clinic • Oncology Board eligible – 2 year fellowship • 12 months service time • 12 months research • Laboratory or Clinical • ½ day continuity clinic • Hematology/Oncology Board eligible (DUAL CERTIFICATION) – 2 year fellowship • 18 months service time • 18 months research • Laboratory or Clinical • ½ day continuity clinic
Research Opportunities • Clinical Research • Specific training in the design/writing of clinical trials • Learn how to consent and enroll patients on trial, record toxicities, and analyze the data • Learn how to present and publish results/learn grant writing • Laboratory Research • Bench research: available in many areas (vascular biology/angiogenesis of tumors, genetic changes, cellular signaling changes, methods of tumor invasion, activity of new drugs, apoptosis/cell death, stem cell biology) • Learn how to present and publish results/learn grant writing • Can combine both clinical and laboratory research – many clinical trials have a laboratory/translational component • MENTOR, MENTOR, MENTOR…….
Heme/Onc board eligible – 3 year program 18 months service time 3 months He2 2 months He1 2 months BMT 3 months Onc2 3 months Consults 1 month Hospice&PC 1 month Heme path 0.5 month Blood bank 2.5 months elective 18 months research Med Onc board eligible – 2 year fellowship 12 months service time 2 months He2 1 months He1 1 months BMT 3 months Onc2 2 months Consults 1 month Hospice&PC 1 month Heme path 1 month elective 12 months research Fellowship requirements
Heme/Onc board certified – 18 months ½ day continuity for all 18 months ½ day ambulatory clinic 6 months benign heme 3 months malignant heme 3 months solid tumor 3 months solid tumor 3 months solid tumor Med Onc certified – 12 months ½ day continuity for all 12 months ½ day ambulatory clinic 3 months malignant heme 3 months malignant heme 3 months solid tumor 3 months solid tumor Clinic schedule
Heme/Onc – 18 months Clinical investigator pathway 2 – ½ day clinics per week ½ day continuity ½ day fellow’s choice Complete CI training (includes writing protocol, LOI, grants, retrospective papers) Laboratory investigator pathway ½ day continuity clinic Laboratory training Med Onc – 12 months Clinical investigator pathway 2 – ½ day clinics per week ½ day continuity ½ day fellow’s choice Complete CI training (includes writing protocol, LOI, grants, retrospective papers) Laboratory investigator pathway ½ day continuity clinic Laboratory training Protected time
Practice Opportunities • Academics • Mostly disease focused • For example: Lung, GI, GU, Breast, Head and Neck, Endocrine, lymphoma, leukemia, myeloma focused • Some portion of protected time to conduct laboratory or clinical research or both • Somewhat less lucrative than private practice • Benefits • disease focus • opportunity to do research • Interact with housestaff, fellows – can participate in education • Share call with faculty, fellows, nurse practitioners
Practice Opportunities • Private practice • Usually all malignancies • Some practices do permit practitioners with some disease focus • Do usually have a few practitioners who see benign hematology, although not all members of the practice may be hematology certified • Fairly Lucrative • Busy call and clinic schedule – frequent consults, cover own inpatients and consults, clinic 3-5 days/week • Benefits • Busy practice, opportunity to see many different malignancies • Limited or no research, although many cancer centers participate in national pharmaceutical or co-operative group trials • Some educational opportunities
Professional Organizations • American Society of Hematology • Focuses on benign and malignant hematology • Clinical and bench research • American Society of Clinical Oncology • Focuses primarily on solid tumors, although some representation of malignant hematology • Clinical and bench research • Co-operative Groups • CALGB, ECOG, SWOG – groups that conduct clinical trials at multiple sites
